Home/Filings/4/0001375151-22-000002
4//SEC Filing

MAST ERLE T 4

Accession 0001375151-22-000002

CIK 0001375151other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 9:23 PM ET

Size

15.7 KB

Accession

0001375151-22-000002

Insider Transaction Report

Form 4
Period: 2022-01-19
MAST ERLE T
Director
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-01-194,3751,250 total
    Exercise: $12.00Exp: 2023-06-18Common Stock (4,375 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-01-19$15.04/sh+6,250$94,0009,277 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-01-19$12.00/sh+4,375$52,50018,027 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-01-196,2500 total
    Exercise: $15.04Exp: 2022-04-27Common Stock (6,250 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-01-194,3750 total
    Exercise: $14.88Exp: 2022-06-06Common Stock (4,375 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-01-19$14.88/sh+4,375$65,10013,652 total
  • Sale

    Stock Option (Right to Buy)

    2022-01-19$26.09/sh15,000$391,2963,027 total
Footnotes (3)
  • [F1]The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2021.
  • [F2]Represents the weighted average sales price per share. The shares were sold at prices ranging from $26.05 to $26.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F3]All of the shares subject to this option are fully vested and exercisable as of the date hereof.

Issuer

ZOGENIX, INC.

CIK 0001375151

Entity typeother

Related Parties

1
  • filerCIK 0001051411

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 9:23 PM ET
Size
15.7 KB